KPL — Kwality Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹22.18bn
- IN₹23.43bn
- IN₹5.03bn
Annual cashflow statement for Kwality Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
R2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Interim Report | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1,616 | 256 | 311 | 541 | 895 |
| Depreciation | |||||
| Non-Cash Items | 28.7 | 59.9 | 171 | 97.1 | 115 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1,145 | -51.4 | -247 | -294 | -1,042 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 606 | 414 | 430 | 527 | 166 |
| Capital Expenditures | -552 | -477 | -298 | -250 | -489 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -77.8 | -7.68 | 34.4 | -35.1 | 140 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -629 | -484 | -264 | -285 | -349 |
| Financing Cash Flow Items | -29.2 | -60.2 | -102 | -98.8 | -110 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 56.6 | 9.94 | -174 | -144 | 70.4 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 33.3 | -60.6 | -8.12 | 97.6 | -113 |